Core Insights - The Lovesac Company has appointed Wan Ling Martello to its Board of Directors, effective November 20, 2025, enhancing its leadership team with her extensive experience in consumer and retail sectors [1][2]. Company Overview - The Lovesac Company, based in Stamford, Connecticut, is a technology-driven furniture brand known for its modular couches called Sactionals and other innovative products designed to evolve with customers' lives [5]. Leadership Experience - Wan Ling Martello has a strong background in driving transformational growth at major consumer and retail companies, including roles as global CFO at Nestlé and senior executive at Walmart, focusing on digital transformation and consumer engagement [2][3]. Strategic Focus - Martello's expertise in data-driven resource allocation and digital transformation aligns with Lovesac's mission as a technology-driven furniture company, which is crucial for navigating its next growth phase [2][3]. Current Roles - In addition to her new role at Lovesac, Martello is currently on the board of the Alibaba Group, further showcasing her extensive industry connections and experience [4].

SEATTLE, Nov. 20, 2025 (GLOBE NEWSWIRE) -- November 20, 2025 – Perspective Therapeutics, Inc. ("Perspective" or the "Company") (NYSE AMERICAN: CATX), a radiopharmaceutical development company pioneering advanced treatments for cancers throughout the body, today announced that members of its senior leadership team will participate in and be available for one-on-one meetings with investors at the following upcoming conferences: Piper Sandler & Co. 37th Annual Healthcare Conference – Fireside ChatDate: Tuesday ...

View PDF Version VANCOUVER, British Columbia, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Yukon Metals Corp. (CSE: YMC, FSE: E770, OTCQB: YMMCF) (“Yukon Metals” or the “Company) is pleased to announce results from the 2025 drill program at its 100% owned Birch Copper-Gold Project (“Birch”), located 65 kilometers northeast of Burwash Landing, Yukon. The Company has received assays from two additional drill holes, BR25-002 and BR25-004, showing a 500m lateral extension to skarn mineralization. Highlights: Drilling at B ...

Core Insights - Can-Fite BioPharma's CF602 targets erectile dysfunction (ED) in diabetic patients and non-responders to existing medications, addressing a significant unmet need in a $3.2 billion market [1][2][3] Company Overview - Can-Fite BioPharma Ltd. is a biotechnology company focused on developing proprietary small molecule drugs for oncological and inflammatory diseases [1][5] - The company has received a Notice of Allowance for its patent application in Brazil, expanding intellectual property protection for CF602 beyond the U.S. and Europe [2] Market Context - The current ED market is valued at $3.2 billion, with standard treatments like Viagra and Cialis effective for approximately 65%-70% of patients [2] - An estimated 30%-35% of ED patients are non-responders to these treatments, and around 16 million men with diabetes are contraindicated from using them [2] Product Details - CF602 is an A3 adenosine receptor (A3AR) allosteric modulator that enhances receptor activity and avoids desensitization, potentially offering a new treatment option for ED [4] - Preclinical studies indicate that CF602 can improve erectile function and vascular health in diabetic models, showing promise for restoring muscle collagen and endothelial function [3][4] Clinical Development - Can-Fite's lead drug candidate, Piclidenoson, is in Phase III trials for psoriasis, while Namodenoson is being evaluated for hepatocellular carcinoma and other cancers [5] - CF602 is positioned as a third drug candidate with demonstrated efficacy in treating erectile dysfunction [5]

Core Points - Alamos Gold Inc. declared a quarterly dividend of US$0.025 per common share and repurchased 928,729 shares for $28.8 million in November 2025 [1][2] - Year-to-date, the company has repurchased 1,326,929 shares for $38.8 million, returning a total of $81 million to shareholders through dividends and share buybacks in 2025 [2] - The dividend is payable on December 18, 2025, to shareholders of record as of December 4, 2025, and qualifies as an "eligible dividend" for Canadian income tax purposes [3] Dividend Reinvestment Plan - The company offers a Dividend Reinvestment Plan (DRIP) allowing shareholders to receive common shares instead of cash dividends at a 1% discount to the market price [4] - Enrollment in the DRIP is optional, and shareholders must complete enrollment by 4:00 pm ET on the fifth business day prior to the dividend record date [5] Company Overview - Alamos Gold is a Canadian-based intermediate gold producer with operations in North America, including the Island Gold District and Young-Davidson mine in Ontario, and the Mulatos District in Mexico [6] - The company has a strong portfolio of growth projects, including the Phase 3+ Expansion at Island Gold and the Lynn Lake project in Manitoba, employing over 2,400 people [6]

Core Insights - The company announced the acquisition of three properties in Richmond, Virginia for $20.7 million, totaling 177,441 square feet and fully leased [1] - Walmart Supercenter, with an AA credit rating, is the anchor tenant of one property, while another property is anchored by TJ Maxx, which has an A credit rating [1][2] - Following this acquisition, approximately 50% of the company's annualized base rent is now derived from investment-grade rated tenants [2] Property and Market Details - The properties are located on 14 acres in a strong market area, with an average household income of $146,000 and a population exceeding 200,000 within a five-mile radius [3] - The acquisition marks the introduction of the first TJ Maxx-branded store into the company's portfolio [2] Company Overview - Alpine Income Property Trust, Inc. is a publicly traded real estate investment trust focused on delivering attractive risk-adjusted returns and dependable cash dividends through a diversified portfolio of single-tenant net leased commercial properties [4]

Core Insights - Bath & Body Works, Inc. announced a comprehensive transformation plan called the Consumer First Formula aimed at revitalizing the brand and driving sustainable long-term growth [2][3] - The company reported third-quarter 2025 results with net sales of $1.594 billion, a decrease of 1% compared to the same quarter in 2024, and earnings per diluted share of $0.37, down from $0.49 [9][10] Strategic Transformation Plan - The Consumer First Formula focuses on four key priorities: creating disruptive and innovative products, reigniting the brand, winning in the marketplace, and operating with speed and efficiency [3] - The plan aims to attract younger consumers and unlock new growth opportunities [2] Financial Performance - Third-quarter net sales were $1,594 million, down from $1,610 million in the same quarter last year, representing a 1% decline [10][28] - Earnings per diluted share for the third quarter were $0.37, compared to $0.49 in the previous year [10][32] - Operating income decreased to $161 million from $218 million year-over-year [10][22] Guidance and Outlook - The company lowered its fourth-quarter 2025 net sales guidance to a decline in high single digits compared to $2,788 million in Q4 2024 [12] - Full-year 2025 net sales guidance was revised from a growth of 1.5% to 2.7% to a decline in low single digits compared to $7,307 million in fiscal 2024 [13] - The expected earnings per diluted share for full-year 2025 is now at least $2.83, down from $3.61 in fiscal 2024 [13] Cost Savings Initiatives - The company plans to deliver $250 million in cost savings over two years, with over half identified for 2026, to fund revenue-generating initiatives [7][9]

Core Viewpoint - Piedmont Realty Trust, Inc. has successfully completed a cash tender offer for its outstanding 9.250% senior notes due 2028, with a significant portion of the notes tendered by the expiration time [1][3]. Summary by Relevant Sections Tender Offer Details - The cash tender offer was announced on November 13, 2025, and the expiration time was set for November 19, 2025 [1]. - A total of $532,460,000 in principal amount of the notes was outstanding, with $244,639,000 (45.95%) tendered by the expiration time and an additional $3,829,000 (0.72%) tendered pursuant to guaranteed delivery procedures [2]. Acceptance and Consideration - The Operating Partnership accepted all validly tendered notes and will pay a total consideration of $1,114.09 for each $1,000 principal amount of notes, plus accrued and unpaid interest [3]. - Notes tendered under guaranteed delivery procedures are expected to be accepted by November 21, 2025, with a settlement date anticipated on November 24, 2025 [3]. Management and Execution - BofA Securities, Inc., TD Securities (USA) LLC, and Wells Fargo Securities acted as dealer managers for the tender offer [4]. Company Overview - Piedmont Realty Trust is a fully integrated, self-managed real estate investment company focused on delivering exceptional office environments, managing approximately 16 million square feet of Class A properties across major U.S. Sunbelt markets [6][7].

Core Insights - Liquidity Services reported strong financial results for Q4 and fiscal year 2025, driven by market share expansion and operational efficiency, with annual GMV surpassing $1.5 billion [1][5][6] Fourth Quarter Results - GMV for Q4 FY2025 was $404.5 million, a 12% increase from $361.0 million in Q4 FY2024 [6] - Revenue for Q4 FY2025 was $118.1 million, up 10% from $106.9 million in Q4 FY2024 [9] - GAAP Net Income for Q4 FY2025 was $7.8 million, a 23% increase from $6.4 million in the same quarter last year [7] - Non-GAAP Adjusted EBITDA for Q4 FY2025 was $18.5 million, reflecting a 28% increase from $14.5 million in Q4 FY2024 [15] Fiscal Year 2025 Results - Annual GMV reached $1.57 billion, a 15% increase from $1.37 billion in FY2024 [7] - Total revenue for FY2025 was $476.7 million, up 31% from $363.3 million in FY2024 [7] - GAAP Net Income for FY2025 was $28.1 million, a 41% increase from $19.99 million in FY2024 [7] Segment Performance - GMV in the CAG segment increased by 18%, driven by growth in recurring sellers and international sales [8] - GMV in the GovDeals segment rose by 12%, supported by new seller acquisitions and service expansions [8] - GMV in the RSCG segment increased by 8%, aided by improved inventory turnover and multi-channel buyer development [8] Operational Metrics - The number of registered buyers reached approximately 6.0 million, a 10% increase from 5.5 million at the end of Q4 FY2024 [20] - Auction participants totaled approximately 1.01 million in Q4 FY2025, remaining relatively flat compared to 1.02 million in Q4 FY2024 [20] - Completed transactions were approximately 269,000 in Q4 FY2025, a 4% decrease from 279,000 in Q4 FY2024 [20] Business Outlook - The company anticipates double-digit growth in profitability metrics for Q1 FY2026, driven by a higher-margin business mix [18] - The fiscal second half of the year is expected to show higher GMV and profitability compared to the first half of FY2026 [19] - Guidance for Q1 FY2026 includes GMV expectations between $370 million and $405 million [21]

Core Insights - Jacobs Solutions Inc. reported a 6.6% year-over-year increase in gross revenue for the fiscal fourth quarter of 2025, reaching $3.2 billion, while adjusted net revenue grew by 5.8% to $2.2 billion [1][9] - The company achieved a record backlog of $23.1 billion, with a trailing twelve months (TTM) book-to-bill ratio of 1.1x, indicating strong demand for its services [1][9] - Jacobs returned a record $1.1 billion to shareholders through share repurchases and dividends during fiscal 2025, reflecting a robust balance sheet and positive cash generation outlook [1][2] Fiscal Year 2025 Financial Highlights - Total revenue for fiscal 2025 was $12.0 billion, up 4.6% from $11.5 billion in fiscal 2024, with adjusted net revenue increasing by 5.3% to $8.7 billion [7][9] - GAAP net earnings from continuing operations were $313 million, a decrease of 48.9% year-over-year, primarily due to mark-to-market losses related to the company's investment in Amentum stock [9][19] - Adjusted EPS from continuing operations rose by 15.9% to $6.12, while GAAP EPS decreased by 46.1% to $2.58 [9][19] Fourth Quarter 2025 Review - In Q4 2025, Jacobs reported revenue of $3.2 billion, a 6.6% increase from $2.96 billion in Q4 2024, with adjusted net revenue of $2.2 billion, up 5.8% [6][9] - Adjusted EBITDA for Q4 was $324 million, reflecting a 12.0% increase year-over-year [9] - The effective tax rate from continuing operations was 28.6%, up from 18.9% in the previous year [6] Financial Outlook for Fiscal 2026 - The company anticipates adjusted net revenue growth of 6% to 10% for fiscal 2026, with adjusted EBITDA margin expected to range from 14.4% to 14.7% [3] - Adjusted EPS is projected to be between $6.90 and $7.30, and free cash flow margin is expected to be between 7.0% and 8.0% [3] Strategic Commentary - Jacobs' CEO highlighted strong performance across key sectors such as Life Sciences, Data Center, Water, Energy & Power, and Transportation, which are expected to drive growth in fiscal 2026 and beyond [2] - The CFO noted that the company exceeded its margin expansion targets and plans to continue returning capital to shareholders, supported by a strong balance sheet and cash generation outlook [2]